XETICAM (Levetiracetam) is indicated as:

Monotherapy:

• in the treatment of partial-onset seizures with or without secondary generalization in adults and adolescents from 16 years of age with newly diagnosed epilepsy.

Adjunctive Therapy:

• in the treatment of partial-onset seizures with or without secondary generalization in adults, adolescents, children, and infants from 1 month of age with epilepsy.
• in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.
• in the treatment of primary generalized tonic-clonic seizures in adults and adolescents from 6 years of age with Idiopathic Generalized Epilepsy.